Seliforant is a selective histamine H4 receptor antagonist. References: Venail F, Attali P, Wersinger E, Gomeni R, Poli S, Schmerber S. Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H(4) receptor inhibitor SENS-111 using a modified caloric test in healthy subjects. Br J Clin Pharmacol. 2018 Dec;84(12):2836-2848. doi: 10.1111/bcp.13744. Epub 2018 Oct 1. PubMed PMID: 30152527; PubMed Central PMCID: PMC6255991.

纯度：≥98%

CAS：1164115-89-2